JENNA DAFFER: Open Payments
NPI 1215569942 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 7 payments from 7 companies in 2025. Trend: 2023 $848 · 2024 $315 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| PharmaEssentia USA Corporation | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| ARRAY BIOPHARMA INC | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
Products named: Tecentriq, ENHERTU, BESREMI, KISQALI, BRAFTOVI, KEYTRUDA, INJECTAFER.
Industry payments across VA — which companies pay providers there.
